Impact of body size on first-line Helicobacter pylori eradication success using vonoprazan and amoxicillin dual therapy.
Hiroyuki EtoSho SuzukiChika KusanoHisatomo IkeharaRyoji IchijimaHirotaka ItoKoichi KawabeMasashi KawamuraYoshioki YodaMoriyasu NakaharaTakuji GotodaPublished in: Helicobacter (2021)
Successful H. pylori eradication with VA-dual was associated with the small body size of patients. This therapy may have to be adjusted per body size.